tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

XERS Stock Latest News

Xeris Pharmaceuticals Announces Board Changes with New Appointment
Company AnnouncementsXeris Pharmaceuticals Announces Board Changes with New Appointment
8d ago
8K
XERS
FDA approves Xeris Biopharma’s sNDA of Gvoke VialDx as gastro diagnostic aid
PremiumThe Fly
FDA approves Xeris Biopharma’s sNDA of Gvoke VialDx as gastro diagnostic aid
19d ago
XERS
Xeris Biopharma (XERS) Expects to Ride the Wave of 30% Revenue Growth in 2025
PremiumMarket News
Xeris Biopharma (XERS) Expects to Ride the Wave of 30% Revenue Growth in 2025
25d ago
XERS
Xeris Biopharma’s Earnings Call Highlights Growth and Optimism
PremiumCompany Announcements
Xeris Biopharma’s Earnings Call Highlights Growth and Optimism
26d ago
XERS
Xeris Biopharma price target raised to $6 from $5 at Leerink
PremiumThe Fly
Xeris Biopharma price target raised to $6 from $5 at Leerink
29d ago
XERS
Xeris Biopharma price target raised to $6.50 from $5 at Craig-Hallum
PremiumThe FlyXeris Biopharma price target raised to $6.50 from $5 at Craig-Hallum
29d ago
XERS
Xeris Biopharma price target raised to $4 from $3 at Piper Sandler
Premium
The Fly
Xeris Biopharma price target raised to $4 from $3 at Piper Sandler
29d ago
XERS
Xeris Pharmaceuticals: Strong Growth Potential and Financial Stability Justify Buy Rating
Premium
Ratings
Xeris Pharmaceuticals: Strong Growth Potential and Financial Stability Justify Buy Rating
29d ago
XERS
Xeris Biopharma price target raised to $8 from $6.60 at H.C. Wainwright
PremiumThe Fly
Xeris Biopharma price target raised to $8 from $6.60 at H.C. Wainwright
29d ago
XERS
Xeris Biopharma Reports Record Revenue and Strong 2025 Outlook
PremiumCompany Announcements
Xeris Biopharma Reports Record Revenue and Strong 2025 Outlook
29d ago
XERS
Xeris Biopharma files $250M mixed securities shelf
PremiumThe Fly
Xeris Biopharma files $250M mixed securities shelf
30d ago
XERS
Xeris Biopharma reports Q4 EPS (3c), consensus (2c)
PremiumThe Fly
Xeris Biopharma reports Q4 EPS (3c), consensus (2c)
1M ago
XERS
Xeris Biopharma sees FY25 revenue $255M-$275M, consensus $239.77M
PremiumThe FlyXeris Biopharma sees FY25 revenue $255M-$275M, consensus $239.77M
1M ago
XERS
XERS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
XERS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
XERS
Xeris Pharmaceuticals Appoints New Chief Medical Officer
Premium
Company Announcements
Xeris Pharmaceuticals Appoints New Chief Medical Officer
1M ago
8K
XERS
Xeris Biopharma CEO Ken Johnson to retire, Anh Nguyen to succeed
PremiumThe Fly
Xeris Biopharma CEO Ken Johnson to retire, Anh Nguyen to succeed
1M ago
XERS
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
ALLO
ATYR
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
ADTX
ARDX
Xeris Biopharma raises FY24 revenue view to $203M from $198M-$202M
PremiumThe Fly
Xeris Biopharma raises FY24 revenue view to $203M from $198M-$202M
3M ago
XERS
Xeris Biopharma price target raised to $6.60 from $6 at H.C. Wainwright
PremiumThe FlyXeris Biopharma price target raised to $6.60 from $6 at H.C. Wainwright
5M ago
XERS
Xeris Biopharma downgraded to Neutral from Overweight at Piper Sandler
Premium
The Fly
Xeris Biopharma downgraded to Neutral from Overweight at Piper Sandler
5M ago
XERS
Xeris Biopharma Reports Record Third Quarter Revenue
Premium
Company Announcements
Xeris Biopharma Reports Record Third Quarter Revenue
5M ago
XERS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >